REVIVAL
Dead / Abandoned — Abandoned — failure to respond (as of 20 Oct 2022)
What this means for you
This application is over — abandoned 11 Oct 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79297218
- Mark type
- Design + words
- Filed
- 25 May 2020
- Abandoned
- 11 Oct 2022
- Attorney of record
- Krista Weber Powell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of infectious diseases; inflammatory diseases, kidney diseases, deficiency diseases; pharmaceutical drugs for the treatment of inflammatory diseases, kidney diseases, deficiency diseases, infectious diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders
- Class 042 — Scientific and technological services: Scientific and technological services, namely, research and design in the field of computer datacenter architecture; scientific, technological and industrial research, namely scientific research, analysis, and reporting in the field of medicine and pharmaceutical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases, autoimmune diseases; industrial analysis and industrial research in the field of medicine and drug development for treating infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; product development of technologies, diagnostics, pharmaceuticals, biotechnological research related to enzymatic synthesis; testing, authentication and quality control of pharmaceuticals for others; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; drug research services; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical drug development services; pharmaceutical product testing; development of pharmaceutical preparations and drugs; consultancy in the field of pharmaceutical research; clinical and medical research; scientific research for medical purposes, namely conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others
Owner
- AM-Pharma B.V., NL
Prosecution history
- 12 Nov 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Oct 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Oct 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 20 Oct 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 20 Oct 2022 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 20 Oct 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 24 Apr 2022 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 07 Apr 2022 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 07 Apr 2022 — FINAL REFUSAL E-MAILED
- 07 Apr 2022 — FINAL REFUSAL WRITTEN
- 06 Apr 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 06 Apr 2022 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 10 Jan 2022 — ASSIGNED TO EXAMINER
- 27 May 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 May 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE